Cybin Inc. (NEO:CYBN)
Canada · Delayed Price · Currency is CAD 9.92
+0.50 (5.31%)
Dec 19, 2025, 11:42 AM EST
Cybin Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
50
Market Cap
464.95M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | 686.88K | - | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.78B |
| dentalcorp Holdings | 1.66B |
| Trulieve Cannabis | 1.66B |
| Green Thumb Industries | 1.61B |
| Extendicare | 1.59B |
| WELL Health Technologies | 1.25B |
| Sienna Senior Living | 967.05M |
| Canopy Growth | 278.61M |
Cybin News
- 23 hours ago - Cybin (CYBN) to Transfer U.S. Listing to Nasdaq, Rebrands to Helus Pharma (HELP) - GuruFocus
- 23 hours ago - Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq - Business Wire
- 1 day ago - Cybin (CYBN) to Transfer Listing to Nasdaq in 2026 - GuruFocus
- 1 day ago - Cybin (CYBN) Set to Switch U.S. Listing from NYSE to Nasdaq - GuruFocus
- 1 day ago - Cybin to move U.S. stock listing to Nasdaq from NYSE American - Seeking Alpha
- 1 day ago - Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq - Business Wire
- 16 days ago - Guggenheim Raises Price Target for Cybin (CYBN) to $48.00 | CYBN Stock News - GuruFocus
- 4 weeks ago - Cybin Inc (CYBN) Q2 2026 Earnings Call Highlights: Strategic Advancements Amid Financial Challenges - GuruFocus